NCT06034626View on ClinicalTrials.gov

Therapeutic Effectiveness of Different Machines in Intense Pulsed Light Treatment of Meibomian Gland Dysfunction

PHASE3CompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

August 10, 2021

Study Completion Date

December 15, 2021

Conditions
MGD-Meibomian Gland Dysfunction
Interventions
PROCEDURE

Intense pulsed light

Each MGD patient underwent three treatment sessions at three-week intervals and three follow-up examinations over the course of treatment.

DRUG

0.3% hyaluronic acid eye drops

0.3% hyaluronic acid eye drops (Hialid; Santen, Osaka, Japan) four times a day during the study, including the follow-up period.

Trial Locations (3)

310000

2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

430000

Hankou Aier Eye Hospital, Wuhan，Hubei Province, Wuhan

Wuhan Aier Eye Hospital, Wuhan，Hubei Province, Wuhan

All Listed Sponsors
collaborator

Aier Eye Hospital, Wuhan

UNKNOWN

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06034626 - Therapeutic Effectiveness of Different Machines in Intense Pulsed Light Treatment of Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter